Abilify sNDA For Major Depressive Disorder Gets Priority Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol/Otsuka are seeking a broader indication for the atypical antipsychotic for MDD as adjunctive to antidepressant therapy.